Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705067 · ClinicalTrials.gov registry record
Safety and Efficacy of the Journey II BCS Total Knee System
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 209
- Enrollment target
NCT01705067: Completed study, sponsored by Smith & Nephew.
NCT01705067 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705067 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 209 participants
- Enrollment target
Study Summary
Assess the safety and efficacy of the JOURNEY II BCS Total Knee System in subjects with degenerative knee disease requiring primary total knee replacement.
Interventions
- DEVICE TKA with Journey II BCS Total Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2012-06 |
| Est. Completion | 2023-07-31 |
What the finished NCT01705067 record still lists
NCT01705067 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which TKA with Journey II BCS Total Knee System is the first listed.
NCT01705067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01705067 about?
NCT01705067 is a clinical study titled "Safety and Efficacy of the Journey II BCS Total Knee System". Assess the safety and efficacy of the JOURNEY II BCS Total Knee System in subjects with degenerative knee disease requiring primary total knee replacement.
What is the current status of trial NCT01705067?
This trial is currently completed. The enrollment target is 209 participants. The study started on 2012-06. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT01705067?
The interventions under investigation include: TKA with Journey II BCS Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT01705067?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia